{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:25:42Z","timestamp":1763036742815},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00393-012-1080-y","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T17:22:25Z","timestamp":1362072145000},"page":"227-235","source":"Crossref","is-referenced-by-count":2,"title":["Therapie der Myositiden"],"prefix":"10.1007","volume":"72","author":[{"given":"A.D.","family":"Keck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BOR.0b013e328358ac72","volume":"24","author":"Aggarwal","year":"2012","unstructured":"Aggarwal R, Oddis CV (2012) Therapeutic advances in myositis. Curr Opin Rheumatol 24:635\u2013641","journal-title":"Curr Opin Rheumatol"},{"key":"1080_CR2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1080_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"1080_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","volume":"24","author":"Bunch","year":"1981","unstructured":"Bunch TW (1981) Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24:45\u201348","journal-title":"Arthritis Rheum"},{"key":"1080_CR5","unstructured":"Coyle K, Pokrovnichka A, French K et al (2008) A randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis. Arthritis Rheum 58(Suppl):Abstract No:2058"},{"key":"1080_CR6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"1080_CR7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"1080_CR8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","volume":"10","author":"Danieli","year":"2011","unstructured":"Danieli MG, Pettinari L, Moretti R et al (2011) Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev 10:144\u2013149","journal-title":"Autoimmun Rev"},{"key":"1080_CR9","first-page":"CD003643","volume":"8","author":"Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE et al (2012) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 8:CD003643","journal-title":"Cochrane Database Syst Rev"},{"key":"1080_CR10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/WCO.0b013e328357f211","volume":"25","author":"Greenberg","year":"2012","unstructured":"Greenberg SA (2012) Pathogenesis and therapy of inclusion body myositis. Curr Opin Neurol 25:630\u2013639","journal-title":"Curr Opin Neurol"},{"key":"1080_CR11","doi-asserted-by":"crossref","unstructured":"Habers GE, Takken T (2011) Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy \u2013 a systematic review. Rheumatology (Oxford) 50:2113\u20132124","DOI":"10.1093\/rheumatology\/ker292"},{"key":"1080_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1529-8019.2012.01491.x","volume":"25","author":"Lam","year":"2012","unstructured":"Lam C, Vleugels RA (2012) Management of cutaneous dermatomyositis. Dermatol Ther 25:112\u2013134","journal-title":"Dermatol Ther"},{"key":"1080_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S33110","volume":"6","author":"Levine","year":"2012","unstructured":"Levine T (2012) Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series. Drug Des Devel Ther 6:133\u2013139","journal-title":"Drug Des Devel Ther"},{"key":"1080_CR14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0b013e32834b324b","volume":"23","author":"Liang","year":"2011","unstructured":"Liang C, Needham M (2011) Necrotizing autoimmune myopathy. Curr Opin Rheumatol 23:612\u2013619","journal-title":"Curr Opin Rheumatol"},{"key":"1080_CR15","doi-asserted-by":"crossref","unstructured":"Majithia V, Harisdangkul V (2005) Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology (Oxford) 44:386\u2013389","DOI":"10.1093\/rheumatology\/keh499"},{"key":"1080_CR16","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.lpm.2010.12.012","volume":"40","author":"Marie","year":"2011","unstructured":"Marie I (2011) Therapy of polymyositis and dermatomyositis. Presse Med 40:e257\u2013e270","journal-title":"Presse Med"},{"key":"1080_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","volume":"53","author":"Marie","year":"2005","unstructured":"Marie I, Hachulla E, Cherin P et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53:155\u2013165","journal-title":"Arthritis Rheum"},{"key":"1080_CR18","first-page":"S53","volume":"199","author":"Miller","year":"2002","unstructured":"Miller FW, Walsh Y, Saminaden S et al (2002) Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy. J Neurol Sci 199(Suppl 1):S53","journal-title":"J Neurol Sci"},{"key":"1080_CR19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","volume":"326","author":"Miller","year":"1992","unstructured":"Miller FW, Leitman SF, Cronin ME et al (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326:1380\u20131384","journal-title":"N Engl J Med"},{"key":"1080_CR20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"Miller","year":"2002","unstructured":"Miller T, Al-Lozi MT, Lopate G et al (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73:420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1080_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11926-012-0246-6","volume":"14","author":"Mimori","year":"2012","unstructured":"Mimori T, Nakashima R, Hosono Y (2012) Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep 14:264\u2013274","journal-title":"Curr Rheumatol Rep"},{"key":"1080_CR22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10165-011-0534-4","volume":"22","author":"Miyasaka","year":"2012","unstructured":"Miyasaka N, Hara M, Koike T et al. (2012) Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial. Mod Rheumatol 22:382\u2013393","journal-title":"Mod Rheumatol"},{"key":"1080_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","volume":"70","author":"Muscle","year":"2011","unstructured":"Muscle Study Group (2011) A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol 70:427\u2013436","journal-title":"Ann Neurol"},{"key":"1080_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jbspin.2011.03.022","volume":"78","author":"Musuruana","year":"2011","unstructured":"Musuruana JL, Cavallasca JA (2011) Abatacept for treatment of refractory polymyositis. Joint Bone Spine 78:431\u2013432","journal-title":"Joint Bone Spine"},{"key":"1080_CR25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"1080_CR26","doi-asserted-by":"crossref","unstructured":"Pisoni CN, Cuadrado MJ, Khamashta MA et al (2007) Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) 46:516\u2013518","DOI":"10.1093\/rheumatology\/kel336"},{"key":"1080_CR27","first-page":"246","volume":"25","author":"Quartuccio","year":"2007","unstructured":"Quartuccio L, De MG, Scott CA et al (2007) Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features. Clin Exp Rheumatol 25:246\u2013251","journal-title":"Clin Exp Rheumatol"},{"key":"1080_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0889-857X(02)00027-3","volume":"28","author":"Rider","year":"2002","unstructured":"Rider LG (2002) Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 28:935\u2013977","journal-title":"Rheum Dis Clin North Am"},{"key":"1080_CR29","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","volume":"50","author":"Rider","year":"2004","unstructured":"Rider LG, Giannini EH, Brunner HI et al (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50:2281\u20132290","journal-title":"Arthritis Rheum"},{"key":"1080_CR30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acr.20532","volume":"Res","author":"Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM et al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient\/parent global activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):118\u2013157","journal-title":"Arthritis Care"},{"key":"1080_CR31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00002508-200411000-00003","volume":"20","author":"Robinson","year":"2004","unstructured":"Robinson ME, Dannecker EA (2004) Critical issues in the use of muscle testing for the determination of sincerity of effort. Clin J Pain 20:392\u2013398","journal-title":"Clin J Pain"},{"key":"1080_CR32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.10026","volume":"25","author":"Schneider","year":"2002","unstructured":"Schneider C, Gold R, Schafers M et al (2002) Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome. Muscle Nerve 25:286\u2013288","journal-title":"Muscle Nerve"},{"key":"1080_CR33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00415-011-5907-2","volume":"258","author":"Stubgen","year":"2011","unstructured":"Stubgen JP (2011) Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies. J Neurol 258:961\u2013970","journal-title":"J Neurol"},{"key":"1080_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.10125","volume":"46","author":"Takada","year":"2002","unstructured":"Takada K, Bookbinder S, Furie R et al (2002) A pilot study of eculizumab in patients with dermatomyositis. Arthritis Rheum 46:489","journal-title":"Arthritis Rheum"},{"key":"1080_CR35","doi-asserted-by":"crossref","unstructured":"Troyanov Y, Targoff IN, Tremblay JL et al (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84:231\u2013249","DOI":"10.1097\/01.md.0000173991.74008.b0"},{"key":"1080_CR36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"Vlekkert","year":"2010","unstructured":"Vlekkert J van de, Hoogendijk JE, Haan RJ de et al (2010) Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord 20:382\u2013389","journal-title":"Neuromuscul Disord"},{"key":"1080_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"Vencovsky","year":"2000","unstructured":"Vencovsky J, Jarosova K, Machacek S et al (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29:95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"1080_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","volume":"41","author":"Villalba","year":"1998","unstructured":"Villalba L, Hicks JE, Adams EM et al (1998) Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41:392\u2013399","journal-title":"Arthritis Rheum"},{"key":"1080_CR39","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","volume":"70","author":"Wang","year":"2011","unstructured":"Wang D, Zhang H, Cao M et al (2011) Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis 70:1285\u20131288","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-1080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-012-1080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-1080-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:36:13Z","timestamp":1559046973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-012-1080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s00393-012-1080-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}